Similarly, no difference was noted in PSMA-11 or FDG uptake between high and low Gleason scores for lymph node metastases (P > 0.05 for both, Figure 5). This evidence concerns the gene FOLH1 and metastatic malignant neoplasm in the lymph nodes.